Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness
Vivek Patel(Cedars-Sinai Medical Center), Tsun Leung Chan(University of Hong Kong), Ileana Carnevali(University of Insubria), Elisa Alducci(Istituto Oncologico Veneto), Mariarosaria Calvello(European Institute of Oncology), Grazia Artioli(Ospedale di Mirano), Birgitte Bertelsen(Gentofte Hospital), Goska Leslie(University of Cambridge), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Julian Adlard(Chapel Allerton Hospital), Almuth Caliebe(Christian-Albrechts-Universität zu Kiel), Davide Bondavalli(European Institute of Oncology), Bernd Auber(Medizinische Hochschule Hannover), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Marinus J. Blok(Maastricht University), Ian Campbell(The University of Sydney), Angela R. Bradbury(University of Pennsylvania), Daniel Barrowdale(University of Cambridge), I. Bodrogi(Aarhus University Hospital), Julika Borde(University Hospital Cologne), Aðalgeir Arason(University of Iceland), Estela Carrasco(Vall d'Hebron Hospital Universitari), Irene L. Andrulis(University of Toronto), Evan L. Busch(Brigham and Women's Hospital), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Bjarni A. Agnarsson(Reykjavík University), Joan Brunet(Institut Català d'Ornitologia), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Rósa B. Barkardóttir(University of Iceland), Santiago Cabezas-Camarero(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Saundra S. Buys(University of Utah), Susanne E. Boonen(Roskilde Sygehus), Bernardo Bonanni(European Institute of Oncology), Judith Balmañà(Vall d'Hebron Hospital Universitari), Munaza Ahmed(Great Ormond Street Hospital), Bruno Buecher(Université Paris Sciences et Lettres), Simona Agata(Roswell Park Comprehensive Cancer Center), Brita Arver(Karolinska University Hospital), Kristiina Aittomäki(University of Helsinki), Lesley McGuffog(University of Cambridge), Åke Borg(Lund University), Angela Brady(Royal Devon and Exeter Hospital), Valérie Bonadona(Centre Léon Bérard), Carole Brewer(Royal Devon and Exeter Hospital), Alicia Barroso(Spanish National Cancer Research Centre), Angel M. Cronin, Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Muriel Belotti(Institut Curie), Tara M. Friebel(Fox Chase Cancer Center)
Cited by 53
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k